vs
礼蓝动物保健（ELAN）与罗布乐思（RBLX）财务数据对比。点击上方公司名可切换其他公司
罗布乐思的季度营收约是礼蓝动物保健的1.2倍（$1.4B vs $1.1B），罗布乐思净利率更高（-22.3% vs -24.1%，领先1.8%），罗布乐思同比增速更快（43.2% vs 12.2%），罗布乐思自由现金流更多（$308.6M vs $46.0M），过去两年罗布乐思的营收复合增速更高（32.9% vs -2.6%）
礼蓝动物保健是一家美国动物保健制药企业，专注于生产宠物及家畜用药品与疫苗。该公司原为礼来公司旗下子公司，2019年完成分拆独立，目前是全球第三大动物保健企业。
罗布乐思（Roblox Corporation）是总部位于美国加利福尼亚州圣马特奥的游戏企业，由大卫·巴斯祖奇与埃里克·卡塞尔于2004年共同创立。公司核心产品为同名线上游戏创作平台Roblox，于2006年正式上线，截至2024年12月底全球员工规模已超2400人。
ELAN vs RBLX — 直观对比
营收规模更大
RBLX
是对方的1.2倍
$1.1B
营收增速更快
RBLX
高出31.0%
12.2%
净利率更高
RBLX
高出1.8%
-24.1%
自由现金流更多
RBLX
多$262.6M
$46.0M
两年增速更快
RBLX
近两年复合增速
-2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.4B |
| 净利润 | $-276.0M | $-316.0M |
| 毛利率 | 51.5% | 77.7% |
| 营业利润率 | -22.6% | -25.3% |
| 净利率 | -24.1% | -22.3% |
| 营收同比 | 12.2% | 43.2% |
| 净利润同比 | -3350.0% | -43.9% |
| 每股收益（稀释后） | $-0.55 | $-0.44 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ELANRBLX
| Q4 25 | $1.1B | $1.4B | ||
| Q3 25 | $1.1B | $1.4B | ||
| Q2 25 | $1.2B | $1.1B | ||
| Q1 25 | $1.2B | $1.0B | ||
| Q4 24 | $1.0B | $988.2M | ||
| Q3 24 | $1.0B | $919.0M | ||
| Q2 24 | $1.2B | $893.5M | ||
| Q1 24 | $1.2B | $801.3M |
净利润ELANRBLX
| Q4 25 | $-276.0M | $-316.0M | ||
| Q3 25 | $-34.0M | $-255.6M | ||
| Q2 25 | $11.0M | $-278.4M | ||
| Q1 25 | $67.0M | $-215.1M | ||
| Q4 24 | $-8.0M | $-219.6M | ||
| Q3 24 | $364.0M | $-239.3M | ||
| Q2 24 | $-50.0M | $-205.9M | ||
| Q1 24 | $32.0M | $-270.6M |
毛利率ELANRBLX
| Q4 25 | 51.5% | 77.7% | ||
| Q3 25 | 53.4% | 78.2% | ||
| Q2 25 | 57.5% | 78.2% | ||
| Q1 25 | 57.3% | 78.3% | ||
| Q4 24 | 50.9% | 77.9% | ||
| Q3 24 | 52.2% | 77.7% | ||
| Q2 24 | 58.2% | 77.8% | ||
| Q1 24 | 57.3% | 77.7% |
营业利润率ELANRBLX
| Q4 25 | -22.6% | -25.3% | ||
| Q3 25 | -4.4% | -21.8% | ||
| Q2 25 | 2.0% | -29.8% | ||
| Q1 25 | 5.0% | -24.6% | ||
| Q4 24 | -5.0% | -24.7% | ||
| Q3 24 | 54.3% | -30.4% | ||
| Q2 24 | -2.7% | -26.6% | ||
| Q1 24 | 1.0% | -37.7% |
净利率ELANRBLX
| Q4 25 | -24.1% | -22.3% | ||
| Q3 25 | -3.0% | -18.8% | ||
| Q2 25 | 0.9% | -25.8% | ||
| Q1 25 | 5.6% | -20.8% | ||
| Q4 24 | -0.8% | -22.2% | ||
| Q3 24 | 35.3% | -26.0% | ||
| Q2 24 | -4.2% | -23.0% | ||
| Q1 24 | 2.7% | -33.8% |
每股收益（稀释后）ELANRBLX
| Q4 25 | $-0.55 | $-0.44 | ||
| Q3 25 | $-0.07 | $-0.37 | ||
| Q2 25 | $0.02 | $-0.41 | ||
| Q1 25 | $0.13 | $-0.32 | ||
| Q4 24 | $-0.01 | $-0.32 | ||
| Q3 24 | $0.73 | $-0.37 | ||
| Q2 24 | $-0.10 | $-0.32 | ||
| Q1 24 | $0.06 | $-0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $545.0M | $3.1B |
| 总债务越低越好 | $3.9B | $1.2B |
| 股东权益账面价值 | $6.5B | $394.5M |
| 总资产 | $13.4B | $9.6B |
| 负债/权益比越低杠杆越低 | 0.60× | 2.98× |
8季度趋势，按日历期对齐
现金及短期投资ELANRBLX
| Q4 25 | $545.0M | $3.1B | ||
| Q3 25 | $505.0M | $2.9B | ||
| Q2 25 | $539.0M | $2.6B | ||
| Q1 25 | $487.0M | $2.7B | ||
| Q4 24 | $468.0M | $2.4B | ||
| Q3 24 | $490.0M | $2.3B | ||
| Q2 24 | $416.0M | $2.4B | ||
| Q1 24 | $345.0M | $2.4B |
总债务ELANRBLX
| Q4 25 | $3.9B | $1.2B | ||
| Q3 25 | $4.0B | — | ||
| Q2 25 | $4.1B | — | ||
| Q1 25 | $4.4B | — | ||
| Q4 24 | $4.3B | $1.2B | ||
| Q3 24 | $4.4B | — | ||
| Q2 24 | $5.7B | — | ||
| Q1 24 | $5.8B | — |
股东权益ELANRBLX
| Q4 25 | $6.5B | $394.5M | ||
| Q3 25 | $6.7B | $407.6M | ||
| Q2 25 | $6.8B | $353.2M | ||
| Q1 25 | $6.4B | $310.7M | ||
| Q4 24 | $6.1B | $221.4M | ||
| Q3 24 | $6.5B | $189.9M | ||
| Q2 24 | $5.9B | $121.5M | ||
| Q1 24 | $6.1B | $71.6M |
总资产ELANRBLX
| Q4 25 | $13.4B | $9.6B | ||
| Q3 25 | $13.6B | $8.6B | ||
| Q2 25 | $13.7B | $7.8B | ||
| Q1 25 | $12.9B | $7.5B | ||
| Q4 24 | $12.6B | $7.2B | ||
| Q3 24 | $13.3B | $6.7B | ||
| Q2 24 | $13.8B | $6.5B | ||
| Q1 24 | $14.0B | $6.3B |
负债/权益比ELANRBLX
| Q4 25 | 0.60× | 2.98× | ||
| Q3 25 | 0.59× | — | ||
| Q2 25 | 0.61× | — | ||
| Q1 25 | 0.69× | — | ||
| Q4 24 | 0.70× | 5.48× | ||
| Q3 24 | 0.67× | — | ||
| Q2 24 | 0.96× | — | ||
| Q1 24 | 0.95× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $108.0M | $607.0M |
| 自由现金流经营现金流 - 资本支出 | $46.0M | $308.6M |
| 自由现金流率自由现金流/营收 | 4.0% | 21.8% |
| 资本支出强度资本支出/营收 | 5.4% | 21.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $284.0M | $1.4B |
8季度趋势，按日历期对齐
经营现金流ELANRBLX
| Q4 25 | $108.0M | $607.0M | ||
| Q3 25 | $219.0M | $546.2M | ||
| Q2 25 | $237.0M | $199.3M | ||
| Q1 25 | $-4.0M | $443.9M | ||
| Q4 24 | $177.0M | $184.5M | ||
| Q3 24 | $162.0M | $247.4M | ||
| Q2 24 | $200.0M | $151.4M | ||
| Q1 24 | $2.0M | $238.9M |
自由现金流ELANRBLX
| Q4 25 | $46.0M | $308.6M | ||
| Q3 25 | $127.0M | $443.6M | ||
| Q2 25 | $180.0M | $176.7M | ||
| Q1 25 | $-69.0M | $426.5M | ||
| Q4 24 | $130.0M | $120.6M | ||
| Q3 24 | $120.0M | $218.0M | ||
| Q2 24 | $166.0M | $111.7M | ||
| Q1 24 | $-22.0M | $192.3M |
自由现金流率ELANRBLX
| Q4 25 | 4.0% | 21.8% | ||
| Q3 25 | 11.2% | 32.6% | ||
| Q2 25 | 14.5% | 16.3% | ||
| Q1 25 | -5.8% | 41.2% | ||
| Q4 24 | 12.7% | 12.2% | ||
| Q3 24 | 11.7% | 23.7% | ||
| Q2 24 | 14.0% | 12.5% | ||
| Q1 24 | -1.8% | 24.0% |
资本支出强度ELANRBLX
| Q4 25 | 5.4% | 21.1% | ||
| Q3 25 | 8.1% | 7.5% | ||
| Q2 25 | 4.6% | 2.1% | ||
| Q1 25 | 5.4% | 1.7% | ||
| Q4 24 | 4.6% | 6.5% | ||
| Q3 24 | 4.1% | 3.2% | ||
| Q2 24 | 2.9% | 4.4% | ||
| Q1 24 | 2.0% | 5.8% |
现金转化率ELANRBLX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 21.55× | — | ||
| Q1 25 | -0.06× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.45× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.06× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ELAN
| Pet Health | $489.0M | 43% |
| Cattle | $296.0M | 26% |
| Poultry | $237.0M | 21% |
| Swine | $107.0M | 9% |
| Contract Manufacturing | $15.0M | 1% |
RBLX
暂无分部数据
